Diabetes
Conditions
Brief summary
In this pilot and feasibility study, the investigator will randomize 100 African-American, Hispanic, and/or Medicaid (all race/ethnicities) patients from KPNW with A1C ≥ 8 to one of two 6-month interventions: 1) patient navigation only; or 2) patient navigation + diabetes self-management training. Feasibility of a large-scale, pragmatic, randomized trial will be determined and preliminary effectiveness of treatment arms on A1C reduction among racial/ethnic minority and low-income patients with poorly managed diabetes will be examined.
Detailed description
The purpose of this feasibility study is to inform the design of a future large-scale, randomized trial that will test if there is added benefit to addressing both social and economic needs and diabetes self-management to improve diabetes management long-term among vulnerable populations. In this pilot, the investigator will randomize 100 African-American, Hispanic, and/or Medicaid (all race/ethnicities) patients from Kaiser Permanente Northwest (KPNW) with A1C ≥ 8 and poor follow-up in primary care to one of two 6-month interventions: 1) patient navigation only; or 2) patient navigation + diabetes self-management training. In both study arms, KPNW practice-embedded patient navigators will screen for medical, social and economic needs and connect participants to internal and external resources. In the second study arm, navigators will also refer participants to community health workers (CHWs) embedded in local community-based organizations, who will deliver diabetes self-management training. Feasibility of the full-scale trial will be based on several measures including recruitment, retention, success rate of referrals to navigators and CHWs, and whether medical, social, and/or economic needs are met. Qualitative interviews will be conducted with various stakeholders to assess intervention acceptability and determinants of implementation. Preliminary effects of A1C, diabetes-related care gaps, health care utilization, and medication adherence will also be examined. This pragmatic study design involves a collaborative effort among researchers, health system staff, health system senior leadership, and local community-based organizations. Findings from the full-scale trial will contribute critical knowledge on the most effective, sustainable model of care for integrating lay health workers in the efforts to improve diabetes management among high risk patient populations.
Interventions
The Decision-making Education for Choices in Diabetes Everyday (DECIDE) program is a nine-module, literacy adapted diabetes and cardiovascular disease education and problem-solving training program. Participants are taught the five steps of problem solving with each module going in depth on a single step: 1) identify the problem; 2) brainstorm possible strategies for problem resolution; 3) select the most appropriate strategy; 4) apply the strategy; 5) evaluate the effectiveness of the strategy. During the six months, CHWs will have weekly or bi-weekly contact with participants in-person or by phone to deliver the DECIDE modules and address social and economic needs.
Once the participant has completed the YCLS assessment with study staff, the navigator will receive the referral and follow-up with the participant to address the social and economic needs identified. The patient navigator will follow-up with the participant 2-3 times over the 6 months by phone or in-person about progress with the referral and help address additional needs that may develop during the 6-month intervention.
Sponsors
Study design
Intervention model description
Eligibility criteria for all study participants is a diagnosis of diabetes with A1C ≥ 8.
Eligibility
Inclusion criteria
* Diabetes diagnosis * Current Kaiser Permanente Northwest member * African-American, Hispanic/Latino (English, Spanish-speaking, or bilingual), and/or a Medicaid recipient (from any racial or ethnic background) * Age 18 or older * Most recent hemoglobin A1C test of ≥ 8 * Endorses 1 or more social and/or economic need on the Your Current Life Situation assessment
Exclusion criteria
* Patients who are unable to provide informed consent due to cognitive or psychiatric impairment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percent of Participants With A1C < 8% | 6 months | Using ITT analysis, percent of participants in each arm with A1C \< 8% at 6-month follow-up was calculated. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Emergency Department (ED) Visits | 6 months | Mean number of visits to the emergency department over the 6-month duration of the intervention. |
| Primary Care Visit No-show Rate | 6 months | Mean number of missed primary care visits over duration of the intervention (6 months) |
| Medication Refills | 6 months | Number of participants with 1 or more gaps in refilling oral diabetes medications during the study period. A gap is defined as not refilling prescription for 7 or more days after prescription has ran out. |
| Mean A1C Change | 6 months | Change in A1C from baseline to 6-month follow-up |
Countries
United States
Participant flow
Recruitment details
We used a targeted recruitment approach by first identifying potentially eligible patients in the electronic health record (EHR) and then emailing or mailing recruitment letters. Letters were followed by a phone call from study staff who described the study and further assessed eligibility by confirming race/ethnicity and health coverage and administering a social risks screener.
Participants by arm
| Arm | Count |
|---|---|
| Patient Navigation Participants randomized to the patient navigation only arm will be referred to a KPNW patient navigator using a standard electronic health record-based referral process. Once the participant has completed the Your Current Life Situation (YCLS) assessment with study staff, the navigator will receive the referral and follow-up with the participant to address the social and economic needs identified. The patient navigator will follow-up with the participant 2-3 times over the 6 month period by phone or in-person about progress with the referral and help address additional needs that may develop during the 6-month intervention. Participant will also receive monthly mailing of American Diabetes Association educational materials.
Standard Patient Navigation: Once the participant has completed the YCLS assessment with study staff, the navigator will receive the referral and follow-up with the participant to address the social and economic needs identified. The patient navigator will follow-up with the participant 2-3 times over the 6 months by phone or in-person about progress with the referral and help address additional needs that may develop during the 6-month intervention. | 54 |
| Patient Navigation+Diabetes Self-Management Support In addition to receiving navigation, participants in this arm will also be referred to Project Access NOW by study staff using REDCap. Project Access NOW will connect participants to a community-based organization based on their preference, previous experience with an agency, geography, and capacity.
The CHW will follow-up with the participant to conduct a home visit and follow-up on community-based referrals already placed by the KPNW patient navigator and assess for additional needs. The timing of the diabetes self-management training will be based on the needs of the participant.
Diabetes Self-Management Training: The Decision-making Education for Choices in Diabetes Everyday (DECIDE) program is a nine-module, literacy adapted diabetes and cardiovascular disease education and problem-solving training program. Participants are taught the five steps of problem solving with each module going in depth on a single step: 1) identify the problem; 2) brainstorm possible strategies for problem resolution; 3) select the most appropriate strategy; 4) apply the strategy; 5) evaluate the effectiveness of the strategy. During the six months, CHWs will have weekly or bi-weekly contract with participants in-person or by phone to deliver the DECIDE modules and address social and economic needs. | 56 |
| Total | 110 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to follow-up for intervention | 12 | 3 |
| Overall Study | Received only 1 component of intervention | 0 | 13 |
Baseline characteristics
| Characteristic | Total | Patient Navigation+Diabetes Self-Management Support | Patient Navigation |
|---|---|---|---|
| A1C | 9.9 % of glycosylated hemoglobin STANDARD_DEVIATION 1.7 | 9.8 % of glycosylated hemoglobin STANDARD_DEVIATION 1.6 | 9.9 % of glycosylated hemoglobin STANDARD_DEVIATION 1.7 |
| Age, Continuous | 53.3 years STANDARD_DEVIATION 12 | 53.7 years STANDARD_DEVIATION 12.1 | 52.9 years STANDARD_DEVIATION 12.1 |
| Primary Language English | 96 Participants | 50 Participants | 46 Participants |
| Primary Language Spanish | 14 Participants | 6 Participants | 8 Participants |
| Race/Ethnicity, Customized Black/African American | 40 Participants | 21 Participants | 19 Participants |
| Race/Ethnicity, Customized Hispanic/Latino | 29 Participants | 13 Participants | 16 Participants |
| Race/Ethnicity, Customized Multiple Races | 3 Participants | 2 Participants | 1 Participants |
| Race/Ethnicity, Customized White | 38 Participants | 20 Participants | 18 Participants |
| Region of Enrollment United States | 110 participants | 56 participants | 54 participants |
| Sex: Female, Male Female | 77 Participants | 39 Participants | 38 Participants |
| Sex: Female, Male Male | 33 Participants | 17 Participants | 16 Participants |
| Types of Social Needs Reported Financial Hardship | 96 Participants | 45 Participants | 51 Participants |
| Types of Social Needs Reported Food Insecurity | 67 Participants | 33 Participants | 34 Participants |
| Types of Social Needs Reported Insufficient Housing | 33 Participants | 18 Participants | 15 Participants |
| Types of Social Needs Reported Lack of Transportation | 37 Participants | 19 Participants | 18 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 1 / 54 | 1 / 56 |
| other Total, other adverse events | 0 / 54 | 0 / 56 |
| serious Total, serious adverse events | 7 / 54 | 7 / 56 |
Outcome results
Percent of Participants With A1C < 8%
Using ITT analysis, percent of participants in each arm with A1C \< 8% at 6-month follow-up was calculated.
Time frame: 6 months
Population: ITT was used for primary outcome analysis so all participants included.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Patient Navigation | Percent of Participants With A1C < 8% | 33 percent of participants |
| Patient Navigation+Diabetes Self-Management Support | Percent of Participants With A1C < 8% | 34 percent of participants |
Emergency Department (ED) Visits
Mean number of visits to the emergency department over the 6-month duration of the intervention.
Time frame: 6 months
Population: Analysis for this secondary outcome includes all participants.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Patient Navigation | Emergency Department (ED) Visits | 0.96 visits | Standard Deviation 1.7 |
| Patient Navigation+Diabetes Self-Management Support | Emergency Department (ED) Visits | 1.07 visits | Standard Deviation 2.95 |
Mean A1C Change
Change in A1C from baseline to 6-month follow-up
Time frame: 6 months
Population: ITT analysis was used for this outcome, so all participants were included in the analysis.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Patient Navigation | Mean A1C Change | 0.65 percentage of glycosylated hemoglobin | Standard Deviation 1.76 |
| Patient Navigation+Diabetes Self-Management Support | Mean A1C Change | 0.72 percentage of glycosylated hemoglobin | Standard Deviation 1.88 |
Medication Refills
Number of participants with 1 or more gaps in refilling oral diabetes medications during the study period. A gap is defined as not refilling prescription for 7 or more days after prescription has ran out.
Time frame: 6 months
Population: Participants who were prescribed an oral diabetes medication during the study.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Patient Navigation | Medication Refills | 27 Participants |
| Patient Navigation+Diabetes Self-Management Support | Medication Refills | 20 Participants |
Primary Care Visit No-show Rate
Mean number of missed primary care visits over duration of the intervention (6 months)
Time frame: 6 months
Population: All participants were included in the analysis for this secondary outcome.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Patient Navigation | Primary Care Visit No-show Rate | 0.85 missed visits | Standard Deviation 1.29 |
| Patient Navigation+Diabetes Self-Management Support | Primary Care Visit No-show Rate | 0.88 missed visits | Standard Deviation 1.62 |